Cardiff Oncology to present preclinical data on drug combination

March 19, 2026 7:02 AM

Cardiff Oncology, Inc. (NASDAQ: CRDF) announced it will present preclinical data on its PLK1 inhibitor onvansertib at the American Association ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found